• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

296.88 +1.78 (+0.60%)
Official Closing Price Updated: 4:15 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,408,889
Open 297.06
Bid (Size) 297.17 (1)
Ask (Size) 298.49 (1)
Prev. Close 295.10
Today's Range 292.59 - 298.52
52wk Range 253.30 - 340.89
Shares Outstanding 537,700,000
Dividend Yield 3.21%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Today 3:22 EDT
President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences. 
Via Benzinga
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
July 31, 2025
Via Stocktwits
Topics Government

Performance

YTD
+14.5%
+14.5%
1 Month
+2.2%
+2.2%
3 Month
+4.6%
+4.6%
6 Month
+4.5%
+4.5%
1 Year
-10.7%
-10.7%

More News

Read More
Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial
July 31, 2025
Via Benzinga
2 Top Dividend Stocks to Buy Right Now and Hold Forever
July 28, 2025
Via The Motley Fool
Topics Intellectual Property
What Analysts Are Saying About Amgen Stock
July 21, 2025
Via Benzinga
This Is What Whales Are Betting On Amgen
July 21, 2025
Via Benzinga
What Does the Market Think About Amgen?
July 11, 2025
Via Benzinga
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
July 25, 2025
Via StockStory
Topics Stocks
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
July 24, 2025
Via Benzinga
2 Reasons to Like AMGN and 1 to Stay Skeptical
July 24, 2025
Via StockStory
Topics Government Stocks
Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest
July 16, 2025
Via StockStory
Topics Artificial Intelligence
1 Unpopular Stock that Deserves a Second Chance and 2 to Keep Off Your Radar
July 15, 2025
Via StockStory
How Does Nvidia's Reaching $4 Trillion in Market Cap Impact the S&P 500, Nasdaq-100, and Dow Jones?
July 14, 2025
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
Via Benzinga
Topics Government World Trade
An Investor Wonders Why Trump's Tariffs Aren't Shaking The Markets. 'Does Wall Street Simply Not Care About The Economy Anymore?'
July 10, 2025
Via Benzinga
Topics Economy Government
This House of Representative Just Bought Up To $30K In Amgen Stock
July 10, 2025
Via Benzinga
1 Top Dividend Growth Stock to Buy Right Now
July 10, 2025
Via The Motley Fool
Topics Intellectual Property
Better Dividend ETF to Buy for Passive Income: SCHD or GCOW
July 03, 2025
Via The Motley Fool
Topics ETFs Stocks
Honeywell, Caterpillar, Freeport-McMoRan And A Health Care Stock On CNBC's 'Final Trades'
July 03, 2025
Via Benzinga
This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
July 01, 2025
Via The Motley Fool
Why Amgen Stock Popped by 4% Today
July 01, 2025
Via The Motley Fool
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
July 01, 2025
Via Benzinga
Topics Stocks
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
June 30, 2025
Via Investor's Business Daily
Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects
June 30, 2025
Via Benzinga
Amgen’s Cancer Drug Improves Survival In Late-stage Trial
June 30, 2025
Via Stocktwits
Topics Death

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 296.88
When was Amgen last traded?
The last trade of Amgen was at 08/01/25 04:15 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 159.63B
How many shares of Amgen are outstanding?
Amgen has 160B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap